Immunologic diseases of the pleura.
This heterogeneous group of immunologic causes of pleural effusions includes connective tissue diseases, a syndrome related to tissue injury (postcardiac injury syndrome), a disease of unknown etiology (sarcoidosis), a malignancy, and adverse reactions to drugs. Except in rheumatoid pleurisy and lupus pleuritis, the pleural fluid findings are either nonspecific or have not been characterized fully. The clinical presentation is essential in the presumptive diagnosis of these causes of pleural effusions.
D000328:Adult; D000368:Aged; D001971:Bromocriptine / Q000009:adverse effects; D006348:Cardiac Surgical Procedures; D003095:Collagen Diseases / Q000150:complications; D003620:Dantrolene / Q000009:adverse effects; D005260:Female; D014890:Granulomatosis with Polyangiitis / Q000150:complications; D006335:Heart Injuries / Q000150:complications; D006801:Humans; D007154:Immune System Diseases; D007119:Immunoblastic Lymphadenopathy / Q000150:complications; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D008784:Methysergide / Q000009:adverse effects; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D009582:Nitrofurantoin / Q000009:adverse effects; D010138:Pacemaker, Artificial / Q000009:adverse effects; D010995:Pleural Diseases / Q000175:diagnosis / Q000209:etiology; D010996:Pleural Effusion / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology*; D011217:Practolol / Q000009:adverse effects; D011344:Procarbazine / Q000009:adverse effects; D012216:Rheumatic Diseases / Q000150:complications; D012507:Sarcoidosis / Q000150:complications; D013577:Syndrome; D013898:Thoracic Injuries / Q000150:complications
D011344:Procarbazine; D001971:Bromocriptine; D009582:Nitrofurantoin; D003620:Dantrolene; D011217:Practolol; D008784:Methysergide; D008727:Methotrexate